These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2252149)

  • 1. [Malignant neoplasms of the ovaries. The diagnostic and therapeutic results].
    Stambolov B; Gorchev G
    Akush Ginekol (Sofiia); 1990; 29(3):51-5. PubMed ID: 2252149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prognostic significance of the histological types of endometrial cancer in relation to the 5-year survival of the patients].
    Stambolov B; Gorchev G
    Akush Ginekol (Sofiia); 1990; 29(5):30-3. PubMed ID: 2091472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnostic and therapeutic results in carcinoma of the cervix uteri].
    Stambolov B; Gorchev G
    Akush Ginekol (Sofiia); 1990; 29(4):51-6. PubMed ID: 2267982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
    Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS
    Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
    Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
    Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonally-active ovarian tumors in 30 years of data (1965-1994)].
    Molnar E; Sloboda L; Fenjvesi A; Zivković S
    Med Pregl; 1999; 52(6-8):241-5. PubMed ID: 10518380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer].
    Ohta M; Tomoda Y; Kano T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline ovarian tumours: clinical analysis of 38 cases.
    Behtash N; Modares M; Abolhasani M; Ghaemmaghami F; Mousavi M; Yarandi F; Hanjani P
    J Obstet Gynaecol; 2004 Feb; 24(2):157-60. PubMed ID: 14766453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
    Venesmaa P
    Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer.
    Högberg T; Carstensen J; Simonsen E
    Gynecol Oncol; 1993 Jan; 48(1):38-49. PubMed ID: 8423020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status of the management of patients with malignant ovarian cancer in Hungary].
    Szánthó A; Szabó I; Demeter A; Papp Z
    Orv Hetil; 1997 Feb; 138(7):405-11. PubMed ID: 9091841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The "age factor" in ovarian cancer. Clinical, therapeutic and prognostic aspects].
    Amunni G; Villanucci A; Tavella K; Veneziano AF; Boddi V; Susini T; Massi GB
    Minerva Med; 1998 Mar; 89(3):65-75. PubMed ID: 9575332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in stage I ovarian carcinoma.
    Vergote I
    Verh K Acad Geneeskd Belg; 2001; 63(3):257-71; discussion 272-6. PubMed ID: 11499346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
    Hannibal CG; Cortes R; Engholm G; Kjaer SK
    Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
    Wu M; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor.
    Massi D; Susini T; Savino L; Boddi V; Amunni G; Colafranceschi M
    Cancer; 1996 Mar; 77(6):1131-6. PubMed ID: 8635134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.